Jeffrey A. Kelman, MD, MMSc

Centers for Medicare & Medicaid Services, Washington, DC, USA, United States

Disclosure information not submitted.

Presentation(s):

• Assessment of Potential Adverse Events Following the 2022–2023 Seasonal Influenza Vaccines Among U.S. Adults Aged 65 Years and Older

  Monday, August 26, 2024
  2:30 PM – 2:45 PM CEST

• Stroke Risk Following Receipt of COVID-19 Bivalent Vaccines Among U.S. Adults Aged ≥65 Years

  Monday, August 26, 2024
  6:00 PM – 6:15 PM CEST

• Added Benefit and Waning Effectiveness of a Third-Dose mRNA COVID-19 Vaccine in Community-Dwelling Medicare Beneficiaries Aged ≥65 Years in Omicron Period

  Tuesday, August 27, 2024
  8:15 AM – 8:30 AM CEST